0002030065-24-000001.txt : 20240712 0002030065-24-000001.hdr.sgml : 20240712 20240712123526 ACCESSION NUMBER: 0002030065-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240712 DATE AS OF CHANGE: 20240712 EFFECTIVENESS DATE: 20240712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Panacent Bio Inc. CENTRAL INDEX KEY: 0002030065 ORGANIZATION NAME: IRS NUMBER: 984887652 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-518567 FILM NUMBER: 241113816 BUSINESS ADDRESS: STREET 1: 666 GREENWICH STREET 744 CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 415-710-9061 MAIL ADDRESS: STREET 1: 666 GREENWICH STREET 744 CITY: NEW YORK STATE: NY ZIP: 10014 D 1 primary_doc.xml X0708 D LIVE 0002030065 Panacent Bio Inc. 666 GREENWICH STREET 744 NEW YORK NY NEW YORK 10014 415-710-9061 DELAWARE None None Corporation true 2023 Robert Sebra 666 Greenwich Street #744 New York NY NEW YORK 10014 Executive Officer Director Daniel Charytonowicz 666 Greenwich St #744 New York NY NEW YORK 10014 Executive Officer Biotechnology Decline to Disclose 06b false 2024-06-25 false true false 0 13 13 0 false 1 0 0 0 false Panacent Bio Inc. Robert Sebra Robert Sebra CEO 2024-07-11